Atlas Trials

Beihua Kong

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Beihua Kong

RecordFirmDate
OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer (NCT07153705)Beihua Kong2025-09-01

Track Beihua Kong automatically

Every clearance here is in the API, with alerts when new ones post.